$599

AZ Looks to China for Latest Obesity Deal; January CHMP Meeting Highlights; Regeneron Q4 ’25 Earnings; Lilly Builds New Site in Pennsylvania; Novo Teases Super Bowl Commercial

A series of cardiometabolic-related news items has been observed from AstraZeneca, EMA, Regeneron, Lilly, and Novo Nordisk. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here